Observation of clinical efficacy of esomeprazole in combination of mosapride in the treatment of reflux esophagitis after resection of cardiac carcinoma
Chun Yang
Abstract
Chun Yang
Abstract
Objective To explore the clinical efficacy of esomeprazole in combination of mosapride in the treatment of reflux esophagitis after resection of cardiac carcinoma. Methods 76 patients with reflux esophagitis after resection of cardiac carcinoma were randomized into two group, treatment group and Control group.The treatment group(n=38)received treatment of esomeprazole plus mosapride, and the control group(n=38)received treatment of mosapride only.Improvements of clinical symptoms and endoscoic pathological changes after 8 weeks were observed. Results Clinical efficacy and and endoscope results of treatment group were better than control group, with statistically difference(P<0.05). Conclusion Esomeprazole in combination of mosapride shows more significant clinical efficacy then mosapride only in the treatment of reflux esophagitis after resection of cardiac carcinoma, which is worth a clinical promotion. Key words: Esophagitis, Peptic; Esomeprazole, cardiac carcinoma
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the clinical efficacy of esomeprazole in combination of mosapride in the treatment of reflux esophagitis after resection of cardiac carcinoma. Methods 76 patients with reflux esophagitis after resection of cardiac carcinoma were randomized into two group, treatment group and Control group.The treatment group(n=38)received treatment of esomeprazole plus mosapride, and the control group(n=38)received treatment of mosapride only.Improvements of clinical symptoms and endoscoic pathological changes after 8 weeks were observed. Results Clinical efficacy and and endoscope results of treatment group were better than control group, with statistically difference(P<0.05). Conclusion Esomeprazole in combination of mosapride shows more significant clinical efficacy then mosapride only in the treatment of reflux esophagitis after resection of cardiac carcinoma, which is worth a clinical promotion. Key words: Esophagitis, Peptic; Esomeprazole, cardiac carcinoma
Key concepts: Mosapride, Esomeprazole, Medicine, Reflux esophagitis, Gastroenterology, Internal medicine, Reflux, Esophagitis